By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Reckitt Benckiser Pharmaceuticals Inc. 

Morris Corporate Center IV
399 Interpace Parkway
P.O. Box 225

Parsippany  New Jersey  07054-0225  U.S.A.
Phone: 973-404-2600 Fax: 973-404-5700


SEARCH JOBS


Industry
Pharmaceutical






Company News
AntiOp Partners With Reckitt Benckiser Pharmaceuticals Inc. To Develop Nasally Administered Treatment For Opioid Overdose 5/21/2014 9:24:36 AM
Reckitt Benckiser Pharmaceuticals Inc. Enters Into Agreement To Develop And Market First Naloxone Nasal Treatment For Opioid Overdose 5/19/2014 9:53:02 AM
Reckitt Benckiser Pharmaceuticals Inc. Pharma Unit In The U.S. Is Raided By The Feds 12/6/2013 7:27:38 AM
Reckitt Benckiser Pharmaceuticals Inc. Slides As Its Drugs Fail To Take Effect 12/6/2013 7:24:34 AM
Reckitt Benckiser Pharmaceuticals Inc. Relase: Michael "The Situation" Sorrentino Partners With Community Ambassadors to Show the Reality of Opioid Prescription Painkiller Addiction and Motivate Americans Battling the Disease to "Reset Reality" 9/10/2013 10:03:25 AM
Reckitt Benckiser Pharmaceuticals Inc. Buys Golong Medicine of Anhui, a TCM Maker 2/25/2013 10:49:41 AM
Reckitt Benckiser Pharmaceuticals Inc. Disappointed Over FDA Denial 2/25/2013 7:13:25 AM
FDA Grants Approval for Reckitt Benckiser Pharmaceuticals Inc.'s Suboxone Sublingual Film 8/20/2012 7:58:40 AM
Reckitt Benckiser Pharmaceuticals Inc. Release: New Report Puts Spotlight on Epidemic of Painkiller Abuse and Need for Patient Education and Resources 11/10/2011 2:12:20 PM
Reckitt Benckiser Pharmaceuticals Inc. Release: Launch of Nuromol a New Painkiller Combination 6/28/2011 7:50:02 AM
12
//-->